Some visit links earn us a commission.

Lowest compounded tirzepatide drug price in New Hampshire 2026: $69 a month, plus yearly membership

By John Samaras, price analyst · Prices checked Nov 16, 2026

Compounded tirzepatide, a pharmacy-made version that is not Zepbound or Mounjaro, ships to New Hampshire from $69 a month at Collective, plus a yearly membership, the lowest of the programs we track, read on November 16, 2026. New Hampshire Medicaid does not cover Zepbound for weight loss.

Paying cash for compounded tirzepatide in New Hampshire

Eden logo

Weight loss or money back Eden

compounded tirzepatide
$129/mo

Includes medication, provider review and shipping

Ships to New Hampshire. Same price at every dose.

Collective logo

Lowest monthly drug price Collective

compounded tirzepatide
$69/mo

Ships to New Hampshire. Same price at every dose.

Some links earn us a commission.

Who ships compounded tirzepatide to New Hampshire

  1. Collective: $69 a month
  2. Eden: $129 a month
  3. CoreAge Rx: $129 a month
  4. Embody: $129 a month
  5. SnagRx: $149 a month

Every program on our compounded tirzepatide chart ships to New Hampshire. The full chart has every price.

Does New Hampshire Medicaid cover Zepbound?

New Hampshire Medicaid does not cover Zepbound for weight loss. It does cover Zepbound for obstructive sleep apnea, with prior authorization. New Hampshire Medicaid plans include AmeriHealth Caritas New Hampshire, Well Sense Health Plan and NH Healthy Families (Centene).

New Hampshire Medicaid stopped covering GLP-1s prescribed solely for weight loss on January 1, 2026 (DHHS notice, October 9, 2025): Saxenda, Wegovy and Zepbound are named. Coverage continues for diabetes, heart protection, severe sleep apnea and MASH (a fatty liver disease).

The New Hampshire Medicaid drug list was last reviewed January 1, 2026. Read on November 6, 2026: NH DHHS Division of Medicaid Services notice: Change in Medicaid Coverage for GLP-1 Medications. New Hampshire Medicaid GLP-1 rules.

GLP-1 prescriptions New Hampshire Medicaid paid for

QuarterPrescriptionsMedicaid paidPer prescription
Apr to Jun 20257,604$8.4 million$1,100
Jul to Sep 20258,205$9.1 million$1,110
Oct to Dec 20258,337$9.1 million$1,090
Jan to Mar 20263,253$3.2 million$1,000

New Hampshire Medicaid paid for 3,253 GLP-1 prescriptions in the first quarter of 2026, down 57% from 7,604 in the second quarter of 2025.

Source: CMS State Drug Utilization Data, all GLP-1 brands, before rebates.

Obesity and insurance in New Hampshire

31.6% of adults in New Hampshire had obesity in 2025, by the CDC's state survey, against 33.5% for the US as a whole. 6.8% of New Hampshire residents have no health insurance and 7.4% live below the poverty line (Census SAIPE 2023). Of the largest counties, Coos County has the highest adult obesity rate, 36.4% (CDC PLACES 2025).

CountyAdults with obesityNo health insuranceBelow the poverty line
Hillsborough County33.1%7.4%6.5%
Rockingham County31.2%5.9%5.4%
Strafford County32.4%6.7%9.3%
Merrimack County33.2%6.7%7.7%
Grafton County25.8%6.7%9.4%
Cheshire County29.9%7.0%9.0%
Belknap County30.5%6.6%8.0%
Coos County36.4%8.6%13.5%
Carroll County30.7%6.2%8.8%
Sullivan County33.5%7.8%9.1%

Source: CDC PLACES 2025 for obesity, Census SAIPE 2023 for insurance and poverty.

More for New Hampshire

Compounded tirzepatide is made by a licensed pharmacy to a prescription and is not FDA-approved. A prescriber decides whether it suits you.